| Project/Area Number |
20790080
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Kobe Pharmaceutical University |
|---|
Principal Investigator |
MIKAMI Tadahisa Kobe Pharmaceutical University, 薬学部, 講師 (20330425)
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Project Status |
Completed (Fiscal Year 2009)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2009: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2008: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 糖鎖 / 発現制御 / 発生・分化 / 細胞・組織 / 酵素 / コンドロイチン硫酸 / グリコサミノグリカン / 神経突起伸長 |
|---|
| Research Abstract |
Chondroitin sulfate (CS) chains are major components of extracellular matrix in nervous system, and have a broad impact on various neurobiological phenomena. In this project, regulatory roles of CS in neuritogenesis were investigated using several model systems, and the key findings are as follows : 1) A plasma membrane-tethered cell adhesion molecule, contactin-1, can function as a neuronal cell-surface CS receptor, and mediates neurite extension promoted by an oversulfated CS variant, CS-E. 2) A morpholino-based knockdown of chondroitin 4-O-sulfotransferase-1, which contributes substantially to the in vivo construction of 4-O-sulfated CS, revealed the functional importance of the characteristic CS sulfation codes in motor axon guidance in zebrafish embryogenesis.
|
